Is Amyloid Beta Peptide A Driver Of Inflammaging?
As we age, our bodies often experience a persistent, low-level inflammation, a process scientists call “inflammaging.” This chronic inflammation is a significant factor in the development of many age-related brain disorders. For years, specific protein fragments, known as amyloid beta peptides, have been primarily recognized for their role in forming the characteristic plaques found in the brains of individuals with Alzheimer’s disease. However, recent insights suggest a more nuanced role for these peptides. It turns out that these peptides aren’t solely detrimental; they also perform beneficial functions, such as supporting brain cell activity and acting as a defense against pathogens. Despite these protective roles, their presence can also fuel the very inflammatory processes that contribute to inflammaging. This dual nature implies that while these peptides can offer protection, their accumulation and interactions with various brain cells, including microglia (the brain’s immune cells) and astrocytes (which support neurons), can initiate and intensify inflammatory responses. A deeper understanding of this intricate balance and how these peptides contribute to inflammation in the aging brain could pave the way for novel therapeutic strategies aimed at early intervention in age-related neurodegenerative conditions.
Source: link to paper